Español
Questions About Cancer? 1-800-4-CANCER
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Clinical Trials (PDQ®)

An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)

Basic Trial Information
Trial Description
     Summary
     Eligibility Criteria
Trial Contact Information

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
No phase specifiedNatural history/EpidemiologyActive18 and overPharmaceutical / IndustryML28257
NCT01615068

Trial Description

Summary

This multi-center, prospective observational study will evaluate the treatment p atterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC). Eligible patients will have an initial metastatic breast cancer d iagnosis that has not been previously treated with systemic therapy; patients ma y be enrolled up to 6 months after the diagnosis. Data will be collected for up to 8 years.

Eligibility Criteria

Inclusion Criteria:

  • Adult patients, >/=18 years of age
  • Initial diagnosis of HER2+ MBC, as diagnosed by the treating physician, no more than 6 months prior to study enrollment
  • Availability of cancer-specific historical data points in the patient's medical records

Exclusion Criteria:

  • Any inability to provide informed consent

Trial Contact Information

Trial Lead Organizations/Sponsors

Genentech Incorporated

Clinical TrialsStudy Director

Reference Study ID Number: ML28257 www.roche.com/about_roche/roche_worldwide.htmPh: 888-662-6728 (U.S. Only)
  Email: global.rochegenentechtrials@roche.com

Trial Sites

U.S.A.
Alabama
  Birmingham
 Study Site
  Mobile
 Study Site
Arizona
  Sedona
 Study Site
  Tucson
 Study Site
Arkansas
  Hot Springs
 Study Site
  Jonesboro
 Study Site
  Little Rock
 Study Site
  Rogers
 Study Site
California
  Burbank
 Study Site
  Encinitas
 Study Site
  Fountain Valley
 Study Site
  Fresno
 Study Site
  Fullerton
 Study Site
  Los Angeles
 Study Site
  Palm Springs
 Study Site
  San Francisco
 Study Site
  San Luis Obispo
 Study Site
  Santa Rosa
 Study Site
Colorado
  Denver
 Study Site
Connecticut
  Bridgeport
 Study Site
  Middletown
 Study Site
  New Haven
 Study Site
  Stamford
 Study Site
District of Columbia
  Washington
 Study Site
Florida
  Boca Raton
 Study Site
  Deerfield Beach
 Study Site
  Fort Myers
 Study Site
  Hollywood
 Study Site
  Jacksonville
 Study Site
  Lakeland
 Study Site
  Orlando
 Study Site
  Plantation
 Study Site
  Saint Petersburg
 Study Site
  Titusville
 Study Site
Georgia
  Atlanta
 Study Site
  Marietta
 Study Site
  Savannah
 Study Site
Idaho
  Post Falls
 Study Site
Illinois
  Alton
 Study Site
  Chicago
 Study Site
  Normal
 Study Site
  Park Ridge
 Study Site
  Skokie
 Study Site
  Urbana
 Study Site
Indiana
  Evansville
 Study Site
Iowa
  Ames
 Study Site
  Iowa City
 Study Site
  Mason City
 Study Site
Kansas
  Wichita
 Study Site
Kentucky
  Louisville
 Study Site
Louisiana
  Baton Rouge
 Study Site
Maine
  Portland
 Study Site
Maryland
  Cumberland
 Study Site
  Rockville
 Study Site
  Silver Spring
 Study Site
  Westminster
 Study Site
Michigan
  Grand Rapids
 Study Site
  Kalamazoo
 Study Site
Minnesota
  Edina
 Study Site
  Minneapolis
 Study Site
  St Louis Park
 Study Site
Mississippi
  Jackson
 Study Site
Missouri
  Jefferson City
 Study Site
  Kansas City
 Study Site
  St Louis
 Study Site
Montana
  Billings
 Study Site
  Missoula
 Study Site
Nebraska
  Lincoln
 Study Site
  Omaha
 Study Site
Nevada
  Las Vegas
 Study Site
New Hampshire
  Lebanon
 Study Site
  Portsmouth
 Study Site
New Jersey
  Berkeley Heights
 Study Site
  Denville
 Study Site
  Hackensack
 Study Site
  Morristown
 Study Site
  Paramus
 Study Site
New York
  Cooperstown
 Study Site
  East Setauket
 Study Site
  Jamaica
 Study Site
  New York
 Study Site
North Carolina
  Asheville
 Study Site
  Gastonia
 Study Site
  Greensboro
 Study Site
  Lumberton
 Study Site
  Pinehurst
 Study Site
Ohio
  Cleveland
 Study Site
  Columbus
 Study Site
  Middletown
 Study Site
  Sylvania
 Study Site
Oklahoma
  Oklahoma City
 Study Site
  Tulsa
 Study Site
Pennsylvania
  Dunmore
 Study Site
  Lancaster
 Study Site
  Philadelphia
 Study Site
  Pittsburgh
 Study Site
  Sayre
 Study Site
South Carolina
  Charleston
 Study Site
  Columbia
 Study Site
Tennessee
  Chattanooga
 Study Site
  Kingsport
 Study Site
  Knoxville
 Study Site
  Nashville
 Study Site
Texas
  Abilene
 Study Site
  Bedford
 Study Site
  Bryan
 Study Site
  Dallas
 Study Site
  El Paso
 Study Site
  Fort Worth
 Study Site
  Houston
 Study Site
  McAllen
 Study Site
  Paris
 Study Site
  Tyler
 Study Site
  Waco
 Study Site
  Webster
 Study Site
Utah
  Ogden
 Study Site
  Salt Lake City
 Study Site
Virginia
  Lynchburg
 Study Site
  Newport News
 Study Site
  Richmond
 Study Site
  Winchester
 Study Site
Washington
  Seattle
 Study Site
  Spokane
 Study Site
West Virginia
  Morgantown
 Study Site
Wisconsin
  Madison
 Study Site
  Milwaukee
 Study Site
India
  Pittsfeild
 Study Site

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT01615068
ClinicalTrials.gov processed this data on December 17, 2014

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.

Back to TopBack to Top